NCT02306083

Effect of Glucosamine on Intraocular Pressure

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 41 (estimated)
• Sponsor: Shahid Beheshti University of Medical Sciences · Academic / Other
• Sex: All
• Age: 40 Years
• Healthy volunteers: Accepted

Summary

In this double blind clinical trial 92 patients suffering from rheumatoid arthritis are included. Those with the history of intraocular and corneal surgery, diabetic and heavy smokers are excluded from the study. Before starting the treatment all patients undergo complete ophthalmic exam, corneal biomechanical properties assessment by Ocular Response Analyzer (ORA) and corneal thickness measurement. Patients are randomly assigned to treatment and placebo groups. Those in the treatment groups receive glucosamine sulfate 1500 mg three times a day. Those in placebo arm receive alike capsule with the same schedule. At month 3 and 6 IOP(intraocular pressure), ORA and pachymetry would be checked again.

Conditions

• Intraocular Pressure Changes After Glucosamine Sulfate Consumption.

Interventions

Type	Name	Description
DRUG	Placebo three times a day
DRUG	glucosamine sulfate 1500 mg three times a day

Timeline

• Start date: 2014-07-01
• Primary completion: 2015-06-01
• First posted: 2014-12-03
• Last updated: 2015-05-08

Locations

1 site across 1 country: Iran